These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 21544908)
1. Synthesis of 64Cu(II)-bis(dithiocarbamatebisphosphonate) and its conjugation with superparamagnetic iron oxide nanoparticles: in vivo evaluation as dual-modality PET-MRI agent. Torres Martin de Rosales R; Tavaré R; Paul RL; Jauregui-Osoro M; Protti A; Glaria A; Varma G; Szanda I; Blower PJ Angew Chem Int Ed Engl; 2011 Jun; 50(24):5509-13. PubMed ID: 21544908 [No Abstract] [Full Text] [Related]
2. Simultaneous Preclinical Positron Emission Tomography-Magnetic Resonance Imaging Study of Lymphatic Drainage of Chelator-Free Madru R; Budassi M; Benveniste H; Lee H; Smith SD; Schlyer DJ; Vaska P; Knutsson L; Strand SE Cancer Biother Radiopharm; 2018 Aug; 33(6):213-220. PubMed ID: 30036073 [TBL] [Abstract][Full Text] [Related]
3. Chelator-free synthesis of a dual-modality PET/MRI agent. Chen F; Ellison PA; Lewis CM; Hong H; Zhang Y; Shi S; Hernandez R; Meyerand ME; Barnhart TE; Cai W Angew Chem Int Ed Engl; 2013 Dec; 52(50):13319-23. PubMed ID: 24166933 [No Abstract] [Full Text] [Related]
4. The cell labeling efficacy, cytotoxicity and relaxivity of copper-activated MRI/PET imaging contrast agents. Patel D; Kell A; Simard B; Xiang B; Lin HY; Tian G Biomaterials; 2011 Feb; 32(4):1167-76. PubMed ID: 21035183 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, Cu(II) complexation, 64Cu-labeling and biological evaluation of cross-bridged cyclam chelators with phosphonate pendant arms. Ferdani R; Stigers DJ; Fiamengo AL; Wei L; Li BT; Golen JA; Rheingold AL; Weisman GR; Wong EH; Anderson CJ Dalton Trans; 2012 Feb; 41(7):1938-50. PubMed ID: 22170043 [TBL] [Abstract][Full Text] [Related]
6. Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging. Unterweger H; Janko C; Schwarz M; Dézsi L; Urbanics R; Matuszak J; Őrfi E; Fülöp T; Bäuerle T; Szebeni J; Journé C; Boccaccini AR; Alexiou C; Lyer S; Cicha I Int J Nanomedicine; 2017; 12():5223-5238. PubMed ID: 28769560 [TBL] [Abstract][Full Text] [Related]
7. On the use of superparamagnetic hydroxyapatite nanoparticles as an agent for magnetic and nuclear in vivo imaging. Adamiano A; Iafisco M; Sandri M; Basini M; Arosio P; Canu T; Sitia G; Esposito A; Iannotti V; Ausanio G; Fragogeorgi E; Rouchota M; Loudos G; Lascialfari A; Tampieri A Acta Biomater; 2018 Jun; 73():458-469. PubMed ID: 29689381 [TBL] [Abstract][Full Text] [Related]
8. Intrinsically germanium-69-labeled iron oxide nanoparticles: synthesis and in-vivo dual-modality PET/MR imaging. Chakravarty R; Valdovinos HF; Chen F; Lewis CM; Ellison PA; Luo H; Meyerand ME; Nickles RJ; Cai W Adv Mater; 2014 Aug; 26(30):5119-23. PubMed ID: 24944166 [TBL] [Abstract][Full Text] [Related]
9. Development of multi-functional chelators based on sarcophagine cages. Liu S; Li Z; Conti PS Molecules; 2014 Apr; 19(4):4246-55. PubMed ID: 24705567 [TBL] [Abstract][Full Text] [Related]
10. Ultrasmall superparamagnetic iron oxide nanoparticles for magnetic resonance imaging contrast agent. Zhao X; Zhao H; Chen Z; Lan M J Nanosci Nanotechnol; 2014 Jan; 14(1):210-20. PubMed ID: 24730260 [TBL] [Abstract][Full Text] [Related]
11. Superparamagnetic iron oxide nanoparticles stabilized by a poly(amidoamine)-rhenium complex as potential theranostic probe. Maggioni D; Arosio P; Orsini F; Ferretti AM; Orlando T; Manfredi A; Ranucci E; Ferruti P; D'Alfonso G; Lascialfari A Dalton Trans; 2014 Jan; 43(3):1172-83. PubMed ID: 24169854 [TBL] [Abstract][Full Text] [Related]
12. Development of intravascular contrast agents for MRI using gadolinium chelates. Kittigowittana K; Yang CT; Cheah WC; Chuang KH; Tuang CY; Chang YT; Golay X; Bates RW ChemMedChem; 2011 May; 6(5):781-7. PubMed ID: 21433294 [TBL] [Abstract][Full Text] [Related]
13. Development of a multimodal imaging probe by encapsulating iron oxide nanoparticles with functionalized amphiphiles for lymph node imaging. Yang BY; Moon SH; Seelam SR; Jeon MJ; Lee YS; Lee DS; Chung JK; Kim YI; Jeong JM Nanomedicine (Lond); 2015 Jul; 10(12):1899-910. PubMed ID: 26139125 [TBL] [Abstract][Full Text] [Related]
14. Rapid size-controlled synthesis of dextran-coated, 64Cu-doped iron oxide nanoparticles. Wong RM; Gilbert DA; Liu K; Louie AY ACS Nano; 2012 Apr; 6(4):3461-7. PubMed ID: 22417124 [TBL] [Abstract][Full Text] [Related]
15. Radiolabeled iron oxide nanoparticles as dual-modality SPECT/MRI and PET/MRI agents. Bouziotis P; Psimadas D; Tsotakos T; Stamopoulos D; Tsoukalas C Curr Top Med Chem; 2012; 12(23):2694-702. PubMed ID: 23339765 [TBL] [Abstract][Full Text] [Related]
16. High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging. Werner EJ; Datta A; Jocher CJ; Raymond KN Angew Chem Int Ed Engl; 2008; 47(45):8568-80. PubMed ID: 18825758 [TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging diagnosis of metastatic lymph nodes in a rabbit model: efficacy of PJY10, a new ultrasmall superparamagnetic iron oxide agent, with monodisperse iron oxide core and multiple-interaction ligands. Yoo RE; Choi SH; Cho HR; Jeon BS; Kwon E; Kim EG; Park J; Myeong WJ; Won JK; Lee YS; Kim JH; Park SW; Sohn CH PLoS One; 2014; 9(9):e107583. PubMed ID: 25216040 [TBL] [Abstract][Full Text] [Related]
18. In vivo evaluation of (64)Cu-labeled magnetic nanoparticles as a dual-modality PET/MR imaging agent. Glaus C; Rossin R; Welch MJ; Bao G Bioconjug Chem; 2010 Apr; 21(4):715-22. PubMed ID: 20353170 [TBL] [Abstract][Full Text] [Related]
19. Modified amino-dextrans as carriers of Gd-chelates for retrograde transport and visualization of peripheral nerves by magnetic resonance imaging (MRI). Pashkunova-Martic I; Manzano-Szalai K; Friske J; Aszmann O; Theiner S; Klose MHM; Baurecht D; Trattnig S; Keppler BK; Helbich TH J Inorg Biochem; 2021 Sep; 222():111495. PubMed ID: 34098348 [TBL] [Abstract][Full Text] [Related]
20. Ultrasmall Superparamagnetic Iron Oxide Nanoparticles with Europium(III) DO3A as a Bimodal Imaging Probe. Carron S; Bloemen M; Vander Elst L; Laurent S; Verbiest T; Parac-Vogt TN Chemistry; 2016 Mar; 22(13):4521-7. PubMed ID: 26880696 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]